GC Genome Corporation (KOSDAQ:340450)
South Korea
· Delayed Price · Currency is KRW 7,880.00
-30.00 (-0.38%)
Aug 14, 2025, 3:30 PM KST
GC Genome Market Cap
GC Genome has a market cap or net worth of 186.37 billion as of August 15, 2025.
Market Cap
186.37B
Enterprise Value
181.84B
Revenue
26.95B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,880.00
Market Cap Chart
Since June 11, 2025, GC Genome's market cap has decreased from 262.52B to 186.37B, a decrease of -29.01%. That is a compound annual growth rate of -85.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 186.37B | -29.01% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.52T |
| Celltrion | 38.58T |
| ALTEOGEN | 23.35T |
| Yuhan | 8,561.74B |
| Peptron | 8,235.61B |
| SK Biopharmaceuticals | 7,878.31B |
| PharmaResearch | 7,106.52B |
| LigaChem Biosciences | 5,666.20B |